CORE Kidney Initiative
Cheshire and Merseyside ICB strategies for early detection of CKD and enhanced monitoring by improved coding
Optimising management and evidence-based pharmacological treatment tailored to the patient
Regional value-based care initiatives by codesign of pathways
Education and community in-reach to improve engagement of patients and healthcare providers
- Improve identification and coding of patients within the Cheshire and Mersey region with CKD
- Prevent progression and CVD by ensuring eligible patients receive statin, RAASi, SGLT2i, BP<140/90
- Embed Kidney Failure Risk Equation (KFRE) in laboratory information management systems to improve risk stratification in Primary care, as per NICE guidance.
- Regional dashboard with agreed CKD measures
- ICB collaboration on care management of CKD within Primary care
- Collaboration with the University of Liverpool.
- Collaboration with public health and Liverpool University Hospital Trust to target inclusion health populations
This initiative aims to test a hands-on approach to:
- Standardise Enzymatic Creatinine Assay and CKD EPI across the region
- Process map current CKD pathways in selected pilot practices
- Revise identification elements of the pathway using a Clinical Digital Resource Collaborative (CDRC)
- Improve CKD coding and accuracy
- Medicine Optimisation for patients who require access to NICE (NG203)- recommended medications
- Build a CKD dashboard with CIPHA
- Improve Education and training across the region for CKD
- Establish primary care as the frontline for CKD diagnosis and initiation
Scalable Interventions at practice/PCN CORE4
- Practice based facilitation of good CKD coding through CDRC training
- CKD (clinical/pathway) education delivered to MDT at practice/PCN level
- Sharing treatment decision aids
- Resourcing medicine optimisation
To seek funding to progress to phase two, Healthy Kidney Project embedding roll out of CORE4, Kidney project and establish a gold standard for CKD across the region.
Phase 2 Objectives
- Rolling out CORE4 to 350+ practices, prioritising those in greatest need
- Complete CKD Lab ‘tackling variation work’
- Leverage Combined Intelligence for Population Health Action (CIPHA) case-Finding tool to drive proactive care & achieve a left shift in healthcare delivery
Phase 2 delivery plans
- CKD team delivering CORE4 intervention (1 to 3) at PCN level through workshops
- The medicine optimisation element of CORE4 needs innovative & collaborative solution
- Enhancing proactive care for CKD patients by identifying high-risk individuals using the CIPHA ECF tool and exploring new ways of delivering proactive care
Title | Filename | Date Posted | Extension | Size |
---|---|---|---|---|
CKD cardiovascular risk | CKD_cardiovascular_risk.pptx | 08/04/2025 | pptx | 1.97 MB |
CKD Medicine optimisation | CKD_Medicine_optimisation.pptx | 27/03/2025 | pptx | 1.61 MB |
CKD C&M NWKN Event March 25 | CKD_C_and_M_NWKN_Event_March_25.pptx | 08/04/2025 | pptx | 3.67 MB |